Welcome to our dedicated page for Ehealth news (Ticker: EHTH), a resource for investors and traders seeking the latest updates and insights on Ehealth stock.
eHealth, Inc. reports developments as a private online health insurance marketplace and independent licensed insurance agency serving U.S. consumers. Company updates commonly cover quarterly results, Medicare plan comparison activity, enrollment-season analysis, and the use of data, artificial intelligence and licensed agents to help consumers compare health insurance options from more than 180 insurers.
News also covers product and service expansion across Medicare, ancillary coverage, individual and family insurance, small business coverage, Individual Coverage Health Reimbursement Arrangements and final expense life insurance. Governance updates, board changes and conference participation round out recurring company disclosures.
eHealth (Nasdaq: EHTH) announced that on January 2, 2026 its Compensation Committee granted an inducement restricted stock unit award of 5,000 shares to a new non-executive level employee.
The award was granted under the company's Amended and Restated 2021 Inducement Plan and is subject to a restricted stock unit agreement and the plan's terms. Vesting is over three years, with one-third of the shares vesting on each of the first, second and third anniversaries of the award's vesting commencement date, subject to the employee's continued service. The grant was made as an inducement in accordance with Nasdaq Listing Rule 5635(c)(4).
eHealth (Nasdaq: EHTH) announced a new $125 million asset-based revolving credit facility with Manulife | Comvest on January 6, 2026. The facility carries pricing of SOFR + 6.50%, a three-year maturity, and an optional borrowing base increase of up to $50 million at the lender's option. A portion of the proceeds repaid approximately $70 million outstanding under the Blue Torch term loan and covered transaction fees and expenses.
The company said remaining proceeds will support strategic growth initiatives, including investments in AI-driven capabilities, omni-channel technology, revenue diversification, and general corporate purposes. eHealth also amended an investment agreement related to its convertible Series A preferred stock. Guggenheim Securities served as financial advisor.
eHealth (Nasdaq: EHTH) updated fiscal 2025 guidance after strong Annual Enrollment Period (AEP) results, citing higher-quality direct branded channels, AI screeners, improved persistency and higher Medicare Advantage commission rates.
Updated full-year ranges: Revenue $540.0M–$560.0M; GAAP net income $30M–$45M; Adjusted EBITDA $80M–$95M; operating cash flow $(25.0)M–$0M. The guidance assumes positive net adjustment revenue $40M–$45M.
eHealth (Nasdaq: EHTH) released a December 3, 2025 open-enrollment snapshot showing broad consumer satisfaction but rising costs. 77% of Americans who reviewed 2026 options felt good about coverage, with 86% satisfaction among Medicare beneficiaries and 81% for employer plans.
Survey highlights include strong support for Trump administration actions on insurance and discounted GLP-1 access (59% support), with 33% saying they intend to take a GLP-1 at discounted prices. eHealth plan-analysis found an 8% increase in Medicare Advantage average out-of-pocket maximums to $6,240 and a 2.8% decline in average deductibles to $4,105. 86% of selected Medicare Advantage plans had a $0 monthly premium.
eHealth (Nasdaq: EHTH) on November 12, 2025 expanded Alice, its AI voice agent, to handle enrollment, post-enrollment, and general service calls for Medicare Advantage beneficiaries.
Alice provides application status updates (with plan-provided info), ID card timing, billing contact numbers, and processes Do Not Call requests. Since launching in 2025, Alice achieved a 100% after-hours answer rate, earned an "exceptional" rating from 77% of callers, and increased purchase interest on after-hours calls to 30.9% versus 24.4% for human screeners. eHealth plans future extension of Alice to other plan types.
eHealth (Nasdaq: EHTH) released a Nov. 6, 2025 survey of 1,500+ Americans showing contrast between individual satisfaction and system concerns.
Key findings: 88% are satisfied with their own coverage, 49% rate the U.S. system a C-or-worse, and 73% have delayed or skipped care due to out-of-pocket costs. The survey finds 55% mistakenly believe GLP-1 weight-loss drugs are covered, 72% would try GLP-1s if covered (36% would pay ≥$500/month), 71% are open to AI agents for enrollment, and 68% support employer stipends for shopping ACA plans (ICHRA-style).
eHealth (Nasdaq: EHTH) announced third quarter results for the period ended September 30, 2025 on November 5, 2025. The company posted an earnings press release and presentation and provided a PDF link and investor relations access at https://ir.ehealthinsurance.com.
A live webcast and conference call were scheduled for November 5, 2025 at 5:00 p.m. ET / 4:00 p.m. CT; dial-in number (800) 549-8228 with participant passcode 47090. The live and archived webcast is available under Events & Presentations on the investor relations website.
eHealth (Nasdaq: EHTH) will release third quarter 2025 financial results and host an earnings conference call on November 5, 2025 at 5:00 p.m. Eastern Time.
The call will be hosted by CEO Derrick Duke and CFO John Dolan. Participants may dial (800) 549-8228 with passcode 47090 or listen via live webcast under Events & Presentations on the eHealth investor relations site. A replay will be available two hours after the call and archived for one year. Attendees are advised to join at least 15 minutes early.
eHealth (Nasdaq: EHTH) announced an amendment to its term loan with Blue Torch Finance LLC and lenders that extends the loan maturity to January 29, 2027. The amendment leaves all other key credit terms, including the applicable interest rate, unchanged.
The company said the extension provides additional financial flexibility while it pursues a multi‑phase capital‑structure plan focused on addressing the term loan maturity, leveraging commissions receivable to increase capital access, and resolving its convertible Series A preferred instrument.
eHealth (Nasdaq: EHTH) announced on October 3, 2025 that its Compensation Committee granted an inducement restricted stock unit (RSU) award of 5,000 shares to a new non-executive employee on October 1, 2025.
The award was granted under the Company's Amended and Restated 2021 Inducement Plan and is subject to a restricted stock unit agreement. Vesting is over three years with one-third vesting on each of the first, second and third anniversaries of the vesting commencement date, October 1, 2025, subject to continued service. The grant was made as an inducement in accordance with Nasdaq Listing Rule 5635(c)(4).